It is difficult to explain why increased serum IGF-1 level may have a protective effect on the risk of cervical cancer observed, whereas the unfavorable effect of serum IGF-1 is addressed in certain sex hormone-related cancers, such as prostate or breast cancer (63). This evidence concerns the gene IGF1 and cervical carcinoma.